Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,907,469,656
+$37,369,937 QoQ
Shares Held
15,385,556
-2.8% QoQ
Ownership
0.638%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#23
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 8%
None 7%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $19,386,650,383 across 15 Drug Manufacturers - General names. JNJ ranks #2 (20.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,003,417 | $4,801,818,850 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
15,385,556 | $3,907,469,656 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,486,486 | $2,247,013,450 | |
| 4 | ABBV |
AbbVie Inc.
|
7,236,861 | $1,821,083,699 | |
| 5 | NVS |
Novartis AG
|
8,117,586 | $1,272,188,077 | |
| 6 | AMGN |
Amgen Inc
|
3,413,981 | $1,236,270,798 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,691,951 | $1,134,650,214 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,899,794 | $998,059,971 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,907,469,656 | 15,385,556 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,870,099,719 | 15,832,514 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,570,953,083 | 17,255,149 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,344,220,655 | 18,035,922 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,838,439,145 | 18,582,253 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,803,210,930 | 16,903,105 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,136,542,555 | 14,773,493 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,291,052,428 | 14,137,063 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,921,616,967 | 13,147,352 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,790,409,445 | 11,318,095 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,593,918,839 | 10,169,190 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,431,919,551 | 9,193,705 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,463,699,647 | 8,843,038 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,303,951,915 | 8,412,593 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,483,834,030 | 8,399,853 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,423,887,578 | 8,716,256 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,591,301,883 | 8,964,576 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,674,401,692 | 9,447,620 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,856,336,680 | 10,851,328 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,675,435,399 | 10,374,213 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,696,731,887 | 10,299,453 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,609,279,371 | 9,791,782 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,562,250,983 | 9,926,617 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $1,515,060,198 | 10,176,385 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,456,489,159 | 10,356,888 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,333,651,108 | 10,170,450 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||